NNC0480-0389

DRUG4 trials

Sponsors

Novo Nordisk A/S

Conditions

Diabetes Mellitus, Type 2Healthy VolunteersHealthy Volunteers Type 2 DiabetesObesityOverweight

Phase 1

First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes

CompletedNCT04259801

Novo Nordisk A/SDiabetes Mellitus, Type 2, Healthy Volunteers, Obesity +1

Start: 2020-02-17End: 2022-03-16Updated: 2023-11-13

A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Japanese Men

CompletedNCT04878406

Novo Nordisk A/SHealthy Volunteers Type 2 Diabetes

Start: 2021-05-18End: 2021-07-20Updated: 2023-05-17

A Research Study Looking Into Blood Levels of the Medicine NNC0480-0389 in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function

CompletedNCT05015894

Novo Nordisk A/SDiabetes Mellitus, Type 2

Start: 2021-08-30End: 2022-08-02Updated: 2023-11-13

Phase 2

A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes

CompletedNCT05144984

Novo Nordisk A/SDiabetes Mellitus, Type 2

Start: 2021-11-29End: 2023-03-23Updated: 2026-04-09